These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27434100)

  • 1. The Medicinal Chemistry of Therapeutic Oligonucleotides.
    Wan WB; Seth PP
    J Med Chem; 2016 Nov; 59(21):9645-9667. PubMed ID: 27434100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of sugar-modified oligonucleotides for antisense therapeutics.
    Prakash TP
    Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Synthesis and Biological Application of Modified Oligonucleotides.
    Glazier DA; Liao J; Roberts BL; Li X; Yang K; Stevens CM; Tang W
    Bioconjug Chem; 2020 May; 31(5):1213-1233. PubMed ID: 32227878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward oligonucleotide therapeutics: pharmacodynamic properties.
    Crooke ST
    FASEB J; 1993 Apr; 7(6):533-9. PubMed ID: 7682523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides.
    Bege M; Borbás A
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide therapeutics: chemistry, delivery and clinical progress.
    Sharma VK; Watts JK
    Future Med Chem; 2015; 7(16):2221-42. PubMed ID: 26510815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in the chemistry, analysis and control for the manufacture of therapeutic-grade synthetic oligonucleotides.
    Sinha ND; Michaud DP
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):807-18. PubMed ID: 17987530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule oligonucleotides as smart modality for antiviral therapy: a medicinal chemistry perspective.
    Kar SS; Dhar AK; Palei NN; Bhatt S
    Future Med Chem; 2023 Jun; 15(12):1091-1110. PubMed ID: 37584172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of nucleic acid medicines based on chemical technology.
    Kawamoto Y; Wu Y; Takahashi Y; Takakura Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114872. PubMed ID: 37244354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2'-O-ribonucleic acid modifications.
    Egli M; Minasov G; Tereshko V; Pallan PS; Teplova M; Inamati GB; Lesnik EA; Owens SR; Ross BS; Prakash TP; Manoharan M
    Biochemistry; 2005 Jun; 44(25):9045-57. PubMed ID: 15966728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, hybridization characteristics, and fluorescence properties of oligonucleotides modified with nucleobase-functionalized locked nucleic acid adenosine and cytidine monomers.
    Kaura M; Kumar P; Hrdlicka PJ
    J Org Chem; 2014 Jul; 79(13):6256-68. PubMed ID: 24933409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.
    Menzi M; Lightfoot HL; Hall J
    Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of therapeutic locked nucleos(t)ides.
    Zhou C; Chattopadhyaya J
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):876-98. PubMed ID: 19894196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
    Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
    J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions for medicinal chemistry in the field of oligonucleotide therapeutics.
    Hall J
    RNA; 2023 Apr; 29(4):423-433. PubMed ID: 36693762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building oligonucleotide therapeutics using non-natural chemistries.
    Wilson C; Keefe AD
    Curr Opin Chem Biol; 2006 Dec; 10(6):607-14. PubMed ID: 17049298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotides Containing Aminated 2'-Amino-LNA Nucleotides: Synthesis and Strong Binding to Complementary DNA and RNA.
    Lou C; Samuelsen SV; Christensen NJ; Vester B; Wengel J
    Bioconjug Chem; 2017 Apr; 28(4):1214-1220. PubMed ID: 28332825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-O-[2-(guanidinium)ethyl]-modified oligonucleotides: stabilizing effect on duplex and triplex structures.
    Prakash TP; Püschl A; Lesnik E; Mohan V; Tereshko V; Egli M; Manoharan M
    Org Lett; 2004 Jun; 6(12):1971-4. PubMed ID: 15176796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A status update of modified oligonucleotides for chemotherapeutics applications.
    Sanghvi YS
    Curr Protoc Nucleic Acid Chem; 2011 Sep; Chapter 4():Unit 4.1.1-22. PubMed ID: 21901670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.